Annual short term debt:
$6.34M-$4.22M(-39.96%)Summary
- As of today (May 30, 2025), ARWR annual short term debt is $6.34 million, with the most recent change of -$4.22 million (-39.96%) on September 30, 2024.
- During the last 3 years, ARWR annual short term debt has risen by +$4.09 million (+181.87%).
- ARWR annual short term debt is now -39.96% below its all-time high of $10.56 million, reached on September 30, 2023.
Performance
ARWR Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$71.78M+$63.60M(+776.99%)Summary
- As of today (May 30, 2025), ARWR quarterly short term debt is $71.78 million, with the most recent change of +$63.60 million (+776.99%) on March 31, 2025.
- Over the past year, ARWR quarterly short term debt has increased by +$66.50 million (+1258.22%).
- ARWR quarterly short term debt is now at all-time high.
Performance
ARWR quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
ARWR Short term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.0% | +1258.2% |
| 3 y3 years | +181.9% | +2366.7% |
| 5 y5 years | +100.0% | +10000.0% |
ARWR Short term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.0% | +181.9% | at high | +2594.5% |
| 5 y | 5-year | -40.0% | >+9999.0% | at high | >+9999.0% |
| alltime | all time | -40.0% | >+9999.0% | at high | >+9999.0% |
ARWR Short term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $71.78M(+777.0%) |
| Dec 2024 | - | $8.19M(+29.1%) |
| Sep 2024 | $6.34M(-40.0%) | $6.34M(+4.8%) |
| Jun 2024 | - | $6.05M(+14.5%) |
| Mar 2024 | - | $5.29M(+54.5%) |
| Dec 2023 | - | $3.42M(-67.6%) |
| Sep 2023 | $10.56M(+280.5%) | $10.56M(+274.2%) |
| Jun 2023 | - | $2.82M(+4.1%) |
| Mar 2023 | - | $2.71M(+1.8%) |
| Dec 2022 | - | $2.66M(-4.0%) |
| Sep 2022 | $2.78M(+23.4%) | $2.78M(-3.7%) |
| Jun 2022 | - | $2.88M(-0.9%) |
| Mar 2022 | - | $2.91M(+3.0%) |
| Dec 2021 | - | $2.83M(+25.6%) |
| Sep 2021 | $2.25M(+105.5%) | $2.25M(+74.4%) |
| Jun 2021 | - | $1.29M(+1.4%) |
| Mar 2021 | - | $1.27M(+7.5%) |
| Dec 2020 | - | $1.18M(+8.0%) |
| Sep 2020 | $1.09M(>+9900.0%) | $1.09M(+8.2%) |
| Jun 2020 | - | $1.01M(+47.0%) |
| Mar 2020 | - | $688.50K(+49.3%) |
| Dec 2019 | - | $461.20K(>+9900.0%) |
| Sep 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | $223.80K(+7.3%) | $223.80K(+1.8%) |
| Jun 2018 | - | $219.90K(+1.8%) |
| Mar 2018 | - | $216.00K(+1.8%) |
| Dec 2017 | - | $212.20K(+1.8%) |
| Sep 2017 | $208.50K(+7.3%) | $208.50K(+1.8%) |
| Jun 2017 | - | $204.80K(+1.8%) |
| Mar 2017 | - | $201.20K(+1.8%) |
| Dec 2016 | - | $197.70K(+1.7%) |
| Sep 2016 | $194.30K(-10.7%) | $194.30K(-46.2%) |
| Jun 2016 | - | $361.10K(+64.7%) |
| Mar 2016 | - | $219.30K(+0.4%) |
| Dec 2015 | - | $218.40K(+0.4%) |
| Sep 2015 | $217.50K(-17.6%) | $217.50K(+0.4%) |
| Jun 2015 | - | $216.70K(+0.4%) |
| Mar 2015 | - | $215.80K(+0.8%) |
| Dec 2014 | - | $214.00K(-18.9%) |
| Sep 2014 | $264.00K | $264.00K(+0.3%) |
| Jun 2014 | - | $263.10K(-79.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $1.26M(-0.7%) |
| Dec 2013 | - | $1.27M(+6.6%) |
| Sep 2013 | $1.19M(+278.9%) | $1.19M(+4.2%) |
| Jun 2013 | - | $1.15M(+4.3%) |
| Mar 2013 | - | $1.10M(-4.6%) |
| Dec 2012 | - | $1.15M(+265.9%) |
| Sep 2012 | $314.80K(>+9900.0%) | $314.80K(+47.7%) |
| Jun 2012 | - | $213.20K(+0.8%) |
| Mar 2012 | - | $211.60K(+1.0%) |
| Dec 2011 | - | $209.60K(>+9900.0%) |
| Sep 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(-100.0%) |
| Dec 2010 | - | $500.00K(0.0%) |
| Sep 2010 | $500.00K(-31.2%) | $500.00K(-13.0%) |
| Jun 2010 | - | $574.80K(-27.8%) |
| Mar 2010 | - | $796.40K(-21.4%) |
| Dec 2009 | - | $1.01M(+39.5%) |
| Sep 2009 | $726.50K(-10.4%) | $726.50K(-15.6%) |
| Jun 2009 | - | $860.40K(+2.0%) |
| Mar 2009 | - | $843.40K(+2.0%) |
| Dec 2008 | - | $826.80K(+2.0%) |
| Sep 2008 | $810.50K(+33.7%) | $810.50K(+34.6%) |
| Jun 2003 | - | $602.00K(-0.2%) |
| Mar 2003 | - | $603.00K(-0.5%) |
| Dec 2002 | - | $606.00K(0.0%) |
| Sep 2002 | $606.00K(+15.2%) | $606.00K(0.0%) |
| Jun 2002 | - | $606.00K(+19.8%) |
| Mar 2002 | - | $506.00K(-3.8%) |
| Dec 2001 | - | $526.00K(0.0%) |
| Sep 2001 | $526.00K(+0.4%) | $526.00K(0.0%) |
| Jun 2001 | - | $526.00K(0.0%) |
| Mar 2001 | - | $526.00K(+0.2%) |
| Dec 2000 | - | $525.00K(+0.2%) |
| Sep 2000 | $524.00K(+0.4%) | $524.00K(+0.2%) |
| Jun 2000 | - | $523.00K(-0.4%) |
| Mar 2000 | - | $525.00K(0.0%) |
| Dec 1999 | - | $525.00K |
| Sep 1999 | $522.00K(-49.1%) | - |
| Sep 1998 | $1.02M(+0.1%) | - |
| Sep 1997 | $1.02M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual short term debt year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly short term debt year-on-year change?
What is Arrowhead Pharmaceuticals annual short term debt?
The current annual short term debt of ARWR is $6.34M
What is the all time high annual short term debt for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual short term debt is $10.56M
What is Arrowhead Pharmaceuticals annual short term debt year-on-year change?
Over the past year, ARWR annual short term debt has changed by -$4.22M (-39.96%)
What is Arrowhead Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of ARWR is $71.78M
What is the all time high quarterly short term debt for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly short term debt is $71.78M
What is Arrowhead Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, ARWR quarterly short term debt has changed by +$66.50M (+1258.22%)